Cross Reference Logo
Citations to this article as recorded by CrossRef and RSC Journals (209 citations).

Manufactured tissue-to-tissue barrier chip for modeling the human blood–brain barrier and regulation of cellular trafficking
Jaehoon Kim, Taehee Yoon, Paul Kim, Mandakh Bekhbat, So Mang Kang, Hoon Suk Rho, Song Ih Ahn and YongTae Kim
Lab Chip, 2023, 23, 2990
DOI: 10.1039/D3LC00124E

Generation of flow and droplets with an ultra-long-range linear concentration gradient
Bo Dai, Yan Long, Jiandong Wu, Shaoqi Huang, Yuan Zhao, Lulu Zheng, Chunxian Tao, Shiwei Guo, Francis Lin, Yongfeng Fu, Dawei Zhang and Songlin Zhuang
Lab Chip, 2021, 21, 4390
DOI: 10.1039/D1LC00749A

Development of nano- and microdevices for the next generation of biotechnology, wearables and miniaturized instrumentation
Luna R. Gomez Palacios and A. Guillermo Bracamonte
RSC Adv., 2022, 12, 12806
DOI: 10.1039/D2RA02008D

Microdissected “cuboids” for microfluidic drug testing of intact tissues
Lisa F. Horowitz, Adan D. Rodriguez, Allan Au-Yeung, Kevin W. Bishop, Lindsey A. Barner, Gargi Mishra, Aashik Raman, Priscilla Delgado, Jonathan T. C. Liu, Taranjit S. Gujral, Mehdi Mehrabi, Mengsu Yang, Robert H. Pierce and Albert Folch
Lab Chip, 2021, 21, 122
DOI: 10.1039/D0LC00801J

Hybrid skin chips for toxicological evaluation of chemical drugs and cosmetic compounds
Jong Seung Lee, Jin Kim, Baofang Cui, Su Kyeom Kim, Sun-A Cho, Susun An and Seung-Woo Cho
Lab Chip, 2022, 22, 343
DOI: 10.1039/D1LC00550B

Behaviorome profiling of anti-tumor and pro-tumor human neutrophil subtypes in a microphysiological system
Shuai Shao, Daniel Duncko and Caroline N. Jones
Lab Chip, 2025, 25, 6349
DOI: 10.1039/D5LC00526D

A microfluidic platform for functional testing of cancer drugs on intact tumor slices
A. D. Rodriguez, L. F. Horowitz, K. Castro, H. Kenerson, N. Bhattacharjee, G. Gandhe, A. Raman, R. J. Monnat, R. Yeung, R. C. Rostomily and A. Folch
Lab Chip, 2020, 20, 1658
DOI: 10.1039/C9LC00811J

Patient-derived organotypic tumor spheroids, tumoroids, and organoids: advancing immunotherapy using state-of-the-art 3D tumor model systems
David J. Bozym, David X. Zheng, Or-Yam Revach, Amir Aref and Russell W. Jenkins
Lab Chip, 2025, 25, 3038
DOI: 10.1039/D5LC00062A

Microfluidic technologies for immunotherapy studies on solid tumours
K. Paterson, S. Zanivan, R. Glasspool, S. B. Coffelt and M. Zagnoni
Lab Chip, 2021, 21, 2306
DOI: 10.1039/D0LC01305F

Tumor-on-a-chip platforms to study cancer–immune system crosstalk in the era of immunotherapy
Stefania Parlato, Giulia Grisanti, Giorgia Sinibaldi, Giovanna Peruzzi, Carlo Massimo Casciola and Lucia Gabriele
Lab Chip, 2021, 21, 234
DOI: 10.1039/D0LC00799D

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer, Marco Campisi, Tatsuya Osaki, Koji Haratani, Minyue Chen, Erik H. Knelson, Navin R. Mahadevan, Jessica Ritter, Ryohei Yoshida, Jens Köhler, Atsuko Ogino, Ryu-Suke Nozawa, Shriram K. Sundararaman, Tran C. Thai, Mizuki Homme, Brandon Piel, Sophie Kivlehan, Bonje N. Obua, Connor Purcell, Mamiko Yajima, Thanh U. Barbie, Patrick H. Lizotte, Pasi A. Jänne, Cloud P. Paweletz, Prafulla C. Gokhale and David A. Barbie
Cancer Cell, 2022, 40, 1128
DOI: 10.1016/j.ccell.2022.08.015

Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer
Elena Ivanova, Mari Kuraguchi, Man Xu, Andrew J. Portell, Luke Taus, Irmina Diala, Alshad S. Lalani, Jihyun Choi, Emily S. Chambers, Shuai Li, Shengwu Liu, Ting Chen, Thanh U. Barbie, Geoffrey R. Oxnard, Jacob J. Haworth, Kwok-Kin Wong, Suzanne E. Dahlberg, Amir A. Aref, David A. Barbie, Magda Bahcall, Cloud P. Paweletz and Pasi A. Jänne
Clinical Cancer Research, 2020, 26, 2393
DOI: 10.1158/1078-0432.CCR-19-1844

Modeling Nanocarrier Transport across a 3D In Vitro Human Blood‐Brain–Barrier Microvasculature
Sharon Wei Ling Lee, Marco Campisi, Tatsuya Osaki, Luca Possenti, Clara Mattu, Giulia Adriani, Roger Dale Kamm and Valeria Chiono
Adv Healthcare Materials, 2020, 9
DOI: 10.1002/adhm.201901486

Preclinical liver cancer models in the context of immunoprecision therapy: Application and perspectives
Fei Song and Zhong Chen
WCJD, 2023, 31, 989
DOI: 10.11569/wcjd.v31.i24.989

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright, Angelina M. Cicerchia, Anne Jenney, Matthew D. Perricone, Caitlin E. Mills, Giulia Cattaneo, Marco Ventin, Feng Chen, Martin Q. Rasmussen, Alex Miranda, Or-Yam Revach, Jacy Fang, Amina Fu, Peter J. Bowling, Tatyana Sharova, Aleigha Lawless, Peter K. Sorger, Nabeel Bardeesy, Xinhui Wang, Keith T. Flaherty, Genevieve M. Boland, Arnav Mehta, Moshe Sade-Feldman, Cristina R. Ferrone and Russell W. Jenkins
Cancer Immunology Research, 2025, 13, 210
DOI: 10.1158/2326-6066.CIR-23-1011

A role for microfluidic systems in precision medicine
Jose M. Ayuso, María Virumbrales-Muñoz, Joshua M. Lang and David J. Beebe
Nat Commun, 2022, 13
DOI: 10.1038/s41467-022-30384-7

Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
Shiu Ying Tsao
Exploration of Targeted Anti-tumor Therapy, 2022, 676
DOI: 10.37349/etat.2022.00107

In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids
Mahesh Devarasetty, Steven D. Forsythe, Ethan Shelkey and Shay Soker
Tissue Eng Regen Med, 2020, 17, 759
DOI: 10.1007/s13770-020-00258-4

The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering
Ke-yu Zhao, Yi-xiang Du, Hui-min Cao, Li-ya Su, Xiu-lan Su and Xian Li
Colloids and Surfaces B: Biointerfaces, 2025, 247, 114435
DOI: 10.1016/j.colsurfb.2024.114435

DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges
Akihiko Goto, Yuu Moriya, Miyu Nakayama, Shinji Iwasaki and Syunsuke Yamamoto
Drug Metabolism and Pharmacokinetics, 2024, 56, 101003
DOI: 10.1016/j.dmpk.2024.101003

Engineering Microphysiological Immune System Responses on Chips
Chris P. Miller, Woojung Shin, Eun Hyun Ahn, Hyun Jung Kim and Deok-Ho Kim
Trends in Biotechnology, 2020, 38, 857
DOI: 10.1016/j.tibtech.2020.01.003

Evaluation of the Effects of Solvents Used in the Fabrication of Microfluidic Devices on Cell Cultures
Xiaopeng Wen, Seiichiro Takahashi, Kenji Hatakeyama and Ken-ichiro Kamei
Micromachines, 2021, 12, 550
DOI: 10.3390/mi12050550

Addressing Patient Specificity in the Engineering of Tumor Models
Laura J. Bray, Dietmar W. Hutmacher and Nathalie Bock
Front. Bioeng. Biotechnol., 2019, 7
DOI: 10.3389/fbioe.2019.00217

Engineered models of tumor metastasis with immune cell contributions
Pamela L. Graney, Daniel Naveed Tavakol, Alan Chramiec, Kacey Ronaldson-Bouchard and Gordana Vunjak-Novakovic
iScience, 2021, 24, 102179
DOI: 10.1016/j.isci.2021.102179

Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)
Moshe Lapidot, Abigail E. Case, Dalia Larios, Helen I. Gandler, Chengcheng Meng, Isidora Tošić, Ellen L. Weisberg, Michael J. Poitras, Prafulla C. Gokhale, Cloud P. Paweletz, Klaus Podar, Ravi Salgia, Srinivas V. Saladi, James D. Griffin, David A. Frank, Raphael Bueno and Martin Sattler
Cancers, 2020, 13, 7
DOI: 10.3390/cancers13010007

Microphysiological Systems for Cancer Immunotherapy Research and Development
Yansong Peng and Esak Lee
Advanced Biology, 2024, 8
DOI: 10.1002/adbi.202300077

Engineering in vitro human tissue models through bio-design and manufacturing
Yu Shrike Zhang and Ali Khademhosseini
Bio-des. Manuf., 2020, 3, 155
DOI: 10.1007/s42242-020-00080-w

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells
Thomas J. Gerton, Allen Green, Marco Campisi, Minyue Chen, Iliana Gjeci, Navin Mahadevan, Catherine A. A. Lee, Ranjan Mishra, Ha V. Vo, Koji Haratani, Ze-Hua Li, Kathleen T. Hasselblatt, Bryanna Testino, Trevor Connor, Christine G. Lian, Kevin M. Elias, Patrick Lizotte, Elena V. Ivanova, David A. Barbie and Daniela M. Dinulescu
Cancers, 2023, 15, 4128
DOI: 10.3390/cancers15164128

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Or-Yam Revach, Angelina M. Cicerchia, Ofir Shorer, Claire A. Palin, Boryana Petrova, Seth Anderson, Baolin Liu, Joshua Park, Lee Chen, Arnav Mehta, Samuel J. Wright, Niamh McNamee, Aya Tal-Mason, Giulia Cattaneo, Payal Tiwari, Hongyan Xie, Johanna M. Sweere, Li-Chun Cheng, Natalia Sigal, Elizabeth Enrico, Marisa Miljkovic, Shane A. Evans, Ngan Nguyen, Mark E. Whidden, Ramji Srinivasan, Matthew H. Spitzer, Yi Sun, Tatyana Sharova, Aleigha R. Lawless, William A. Michaud, Martin Q. Rasmussen, Jacy Fang, Jeannette R. Brook, Feng Chen, Xinhui Wang, Cristina R. Ferrone, Donald P. Lawrence, Ryan J. Sullivan, David Liu, Uma M. Sachdeva, Debattama R. Sen, Keith T. Flaherty, Robert T. Manguso, Lloyd Bod, Manolis Kellis, Genevieve M. Boland, Keren Yizhak, Jiekun Yang, Naama Kanarek, Moshe Sade-Feldman, Nir Hacohen and Russell W. Jenkins
Cell Reports Medicine, 2025, 6, 102210
DOI: 10.1016/j.xcrm.2025.102210

Engineering approaches for studying immune-tumor cell interactions and immunotherapy
Sarah E. Shelton, Huu Tuan Nguyen, David A. Barbie and Roger D. Kamm
iScience, 2021, 24, 101985
DOI: 10.1016/j.isci.2020.101985

Organoid and Spheroid Tumor Models: Techniques and Applications
Sreenivasulu Gunti, Austin T.K. Hoke, Kenny P. Vu and Nyall R. London
Cancers, 2021, 13, 874
DOI: 10.3390/cancers13040874

Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology
Hongyan Xie, Jackson W. Appelt and Russell W. Jenkins
Cancers, 2021, 13, 6052
DOI: 10.3390/cancers13236052

Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
Mohammad Rashidian, Martin W. LaFleur, Vincent L. Verschoor, Anushka Dongre, Yun Zhang, Thao H. Nguyen, Stephen Kolifrath, Amir R. Aref, Christie J. Lau, Cloud P. Paweletz, Xia Bu, Gordon J. Freeman, M. Inmaculada Barrasa, Robert A. Weinberg, Arlene H. Sharpe and Hidde L. Ploegh
Proc. Natl. Acad. Sci. U.S.A., 2019, 116, 16971
DOI: 10.1073/pnas.1905005116

3D Immunocompetent Organ‐on‐a‐Chip Models
Sushila Maharjan, Berivan Cecen and Yu Shrike Zhang
Small Methods, 2020, 4
DOI: 10.1002/smtd.202000235

Breast cancer organoids and their applications for precision cancer immunotherapy
Dandan Guan, Xiaozhen Liu, Qingyang Shi, Bangjie He, Chaopeng Zheng and Xuli Meng
World J Surg Onc, 2023, 21
DOI: 10.1186/s12957-023-03231-2

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, Marija Grozdanić, Ana Podolski-Renić and Milica Pešić
Life, 2024, 14, 1142
DOI: 10.3390/life14091142

Immunity‐on‐a‐Chip: Integration of Immune Components into the Scheme of Organ‐on‐a‐Chip Systems
Qasem Ramadan, Rana Hazaymeh and Mohammed Zourob
Advanced Biology, 2023, 7
DOI: 10.1002/adbi.202200312

Radiobiological effects of wound fluid on breast cancer cell lines and human-derived tumor spheroids in 2D and microfluidic culture
Shabnam Jeibouei, Ali Hojat, Ebrahim Mostafavi, Amir Reza Aref, Alireza Kalbasi, Vahid Niazi, Mohammad Ajoudanian, Farzaneh Mohammadi, Fariba Saadati, Seyed Mohammadreza Javadi, Forough Shams, Maryam Moghaddam, Farshid Karami, Kazem Sharifi, Farid Moradian, Mohammad Esmaeil Akbari and Hakimeh Zali
Sci Rep, 2022, 12
DOI: 10.1038/s41598-022-11023-z

Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review)
Annette Affolter, Johann Kern, Karen Bieback, Claudia Scherl, Nicole Rotter and Anne Lammert
Int J Oncol, 2022, 61
DOI: 10.3892/ijo.2022.5378

Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapy
Suresh P．K．, Arindam Banerjee and Preeti Singh
OpenNano, 2023, 10, 100134
DOI: 10.1016/j.onano.2023.100134

Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids
Lanxiang Huang, Yaqi Xu, Na Wang, Kezhen Yi, Xiaodan Xi, Huaqi Si, Qian Zhang, Ming Xiang, Yuan Rong, Yufeng Yuan and Fubing Wang
Small Methods, 2024, 8
DOI: 10.1002/smtd.202301009

Deterministic culturing of single cells in 3D
Rohil Jain, Shirisha Chittiboyina, Chun-Li Chang, Sophie A. Lelièvre and Cagri A. Savran
Sci Rep, 2020, 10
DOI: 10.1038/s41598-020-67674-3

The challenges and considerations for emerging or future entrepreneurial researchers in microphysiological systems
Francois Taute, Antoni Homs-Corbera and Pierre Gaudriault
Open Res Europe, 2021, 1, 38
DOI: 10.12688/openreseurope.13335.1

Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm
Runzhi Xie, Junping Li, Yuxuan Hu, Lin Gao and Rodrigo Mora
PLoS Comput Biol, 2026, 22, e1013973
DOI: 10.1371/journal.pcbi.1013973

Advanced Microfluidics for Single Cell‐Based Cancer Research
Adriana Carneiro, Marta Aranda Palomer, Margarida Esteves, Carolina Rodrigues, José Maria Fernandes, Francisca Oliveira, Alexandra Teixeira, Carlos Honrado, Lorena Dieguez, Sara Abalde‐Cela and Miguel Xavier
Advanced Science, 2025, 12
DOI: 10.1002/advs.202500975

Organoid Models of Tumor Immunology
Kanako Yuki, Ning Cheng, Michitaka Nakano and Calvin J. Kuo
Trends in Immunology, 2020, 41, 652
DOI: 10.1016/j.it.2020.06.010

Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor
Giovanni S. Offeddu, Elena Cambria, Sarah E. Shelton, Kristina Haase, Zhengpeng Wan, Luca Possenti, Huu Tuan Nguyen, Mark R. Gillrie, Dean Hickman, Charles G. Knutson and Roger D. Kamm
Advanced Science, 2024, 11
DOI: 10.1002/advs.202402757

Microfluidics for interrogating live intact tissues
Lisa F. Horowitz, Adán D. Rodriguez, Tyler Ray and Albert Folch
Microsyst Nanoeng, 2020, 6
DOI: 10.1038/s41378-020-0164-0

Strategies for the vascularization and immune modeling of human tumor organoids based on advanced technologies
Rui Li, Qianqian Dong, Honglei Jian and Shuo Bai
Precision Medicine and Engineering, 2025, 2, 100030
DOI: 10.1016/j.preme.2025.100030

Ex Vivo Tumor‐on‐a‐Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment
Vardhman Kumar and Shyni Varghese
Adv Healthcare Materials, 2019, 8
DOI: 10.1002/adhm.201801198

Analysis of Leukocyte Behaviors on Microfluidic Chips
Yan Liu, Qingzhen Yang, Lei Cao and Feng Xu
Adv Healthcare Materials, 2019, 8
DOI: 10.1002/adhm.201801406

Microfluidic Tumor Vasculature Model to Recapitulate an Endothelial Immune Barrier Expressing FasL
Seunggyu Kim, Joonha Park, Jeongsik Kim and Jessie S. Jeon
ACS Biomater. Sci. Eng., 2021, 7, 1230
DOI: 10.1021/acsbiomaterials.0c01542

Engineering the Immune Microenvironment into Organoid Models
Kathleen A. Luckett and Karuna Ganesh
Annu. Rev. Cancer Biol., 2023, 7, 171
DOI: 10.1146/annurev-cancerbio-061421-040659

Advances in Spheroids and Organoids on a Chip
Guocheng Fang, Yu‐Cheng Chen, Hongxu Lu and Dayong Jin
Adv Funct Materials, 2023, 33
DOI: 10.1002/adfm.202215043

Making In Vitro Tumor Models Whole Again
Kenny Zhuoran Wu, Christabella Adine, Aleksandr Mitriashkin, Benjamin Jun Jie Aw, N. Gopalakrishna Iyer and Eliza Li Shan Fong
Adv Healthcare Materials, 2023, 12
DOI: 10.1002/adhm.202202279

Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types
Yaya Yu, Yanan Li, Jiao Wang, Yanjuan Zhu, Zexin Zhang, Zhenzhen Xiao, Yadong Chen, Yanchun Qu, Ling Han and Haibo Zhang
Exp Hematol Oncol, 2026, 15
DOI: 10.1186/s40164-026-00757-5

Antitumor Effects in Gas Plasma-Treated Patient-Derived Microtissues—An Adjuvant Therapy for Ulcerating Breast Cancer?
Zahra Akbari, Fariba Saadati, Hamed Mahdikia, Eric Freund, Fereshteh Abbasvandi, Babak Shokri, Hakimeh Zali and Sander Bekeschus
Applied Sciences, 2021, 11, 4527
DOI: 10.3390/app11104527

Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
Marika Quadri, Alessandra Marconi, Simran K. Sandhu, Alexi Kiss, Tatiana Efimova and Elisabetta Palazzo
Front. Med., 2022, 9
DOI: 10.3389/fmed.2022.875517

Real time monitoring of oxygen uptake of hepatocytes in a microreactor using optical microsensors
Christian Gehre, Marie Flechner, Sarah Kammerer, Jan-Heiner Küpper, Charles Dominic Coleman, Gerhard Paul Püschel, Katja Uhlig and Claus Duschl
Sci Rep, 2020, 10
DOI: 10.1038/s41598-020-70785-6

Functional precision oncology using patient-derived assays: bridging genotype and phenotype
Allard W. J. van Renterghem, Joris van de Haar and Emile E. Voest
Nat Rev Clin Oncol, 2023, 20, 305
DOI: 10.1038/s41571-023-00745-2

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
Kartik Sehgal, Andrew Portell, Elena V. Ivanova, Patrick H. Lizotte, Navin R. Mahadevan, Jonathan R. Greene, Amir Vajdi, Carino Gurjao, Tyler Teceno, Luke J. Taus, Tran C. Thai, Shunsuke Kitajima, Derek Liu, Tetsuo Tani, Moataz Noureddine, Christie J. Lau, Paul T. Kirschmeier, David Liu, Marios Giannakis, Russell W. Jenkins, Prafulla C. Gokhale, Silvia Goldoni, Maria Pinzon-Ortiz, William D. Hastings, Peter S. Hammerman, Juan J. Miret, Cloud P. Paweletz and David A. Barbie
Journal of Clinical Investigation, 2021, 131
DOI: 10.1172/JCI135038

Tumor-on-chip’s alliance with molecular pathology against metastatic disease
Emma Di Carlo
J Biomed Sci, 2026, 33
DOI: 10.1186/s12929-025-01209-8

Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma
Eric R. Molina, Letitia K. Chim, Sergio Barrios, Joseph A. Ludwig and Antonios G. Mikos
Tissue Engineering Part B: Reviews, 2020, 26, 249
DOI: 10.1089/ten.teb.2019.0302

Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma
Jialiang Cai, Lina Song, Feng Zhang, Suiyi Wu, Guiqi Zhu, Peiling Zhang, Shiping Chen, Junxian Du, Biao Wang, Yufan Cai, Yi Yang, Jinglei Wan, Jian Zhou, Jia Fan and Zhi Dai
Cancer Commun, 2024, 44, 1231
DOI: 10.1002/cac2.12607

Organoids in lung cancer brain metastasis: Foundational research, clinical translation, and prospective outlooks
Mei Zheng, Jialin Qu, Dongxi Xiang and Ligang Xing
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025, 1880, 189235
DOI: 10.1016/j.bbcan.2024.189235

Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response
Jia Ning Nicolette Yau and Giulia Adriani
Front. Oncol., 2023, 13
DOI: 10.3389/fonc.2023.1148930

Engineered Tools to Study Intercellular Communication
Benjamin A. Yang, Trisha M. Westerhof, Kaitlyn Sabin, Sofia D. Merajver and Carlos A. Aguilar
Advanced Science, 2021, 8
DOI: 10.1002/advs.202002825

Three‐dimensional in vitro cell culture devices using patient‐derived cells for high‐throughput screening of drug combinations
Seok‐Joon Kwon, Dongwoo Lee, Sneha Gopal, Ashlyn Ku, Hosang Moon and Jonathan S. Dordick
Med Devices & Sens, 2020, 3
DOI: 10.1002/mds3.10067

Combination of anti-miR19a-3p polyplex plus doxorubicin for breast cancer in 2D culture and apoptosis assay in 3D spheroids in a microwell device
Behjat Kheiri Yeghaneh Azar, Mitra Nourbakhsh, M R Nasiraee, Kazem Mousavizadeh, Zahra Madjd, Mohammad Ajoudanian, Sara Saeedi, Amirhossein Vahabi, Michael R Hamblin and Mahdi Karimi
J. Micromech. Microeng., 2024, 34, 015002
DOI: 10.1088/1361-6439/ad0d7f

Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Feihu Xie, Lejia Sun, Yuan Pang, Gang Xu, Bao Jin, Haifeng Xu, Xin Lu, Yiyao Xu, Shunda Du, Yanan Wang, Shi Feng, Xinting Sang, Shouxian Zhong, Xin Wang, Wei Sun, Haitao Zhao, Hongbing Zhang, Huayu Yang, Pengyu Huang and Yilei Mao
Biomaterials, 2021, 265, 120416
DOI: 10.1016/j.biomaterials.2020.120416

3D Collagen Vascular Tumor-on-a-Chip Mimetics for Dynamic Combinatorial Drug Screening
Li Wan, Jun Yin, John Skoko, Russell Schwartz, Mei Zhang, Philip R. LeDuc and Carola A. Neumann
Molecular Cancer Therapeutics, 2021, 20, 1210
DOI: 10.1158/1535-7163.MCT-20-0880

From simplicity to complexity in current melanoma models
Elisabetta Michielon, Tanja D. de Gruijl and Susan Gibbs
Experimental Dermatology, 2022, 31, 1818
DOI: 10.1111/exd.14675

Recent advances in preclinical models for lung squamous cell carcinoma
Yuanwang Pan, Han Han, Kristen E. Labbe, Hua Zhang and Kwok-Kin Wong
Oncogene, 2021, 40, 2817
DOI: 10.1038/s41388-021-01723-7

Synthetic living materials in cancer biology
Shelly R. Peyton, Lesley W. Chow, Stacey D. Finley, Ashlee N. Ford Versypt, Reginald Hill, Melissa L. Kemp, Ellen M. Langer, Alison P. McGuigan, Aaron S. Meyer, Stephanie K. Seidlits, Krishnendu Roy and Shannon M. Mumenthaler
Nat Rev Bioeng, 2023, 1, 972
DOI: 10.1038/s44222-023-00105-w

Engineered in vitro tumor models for cell-based immunotherapy
Yuta Ando, Chelsea Mariano and Keyue Shen
Acta Biomaterialia, 2021, 132, 345
DOI: 10.1016/j.actbio.2021.03.076

Biomedical Applications of Non-Small Cell Lung Cancer Spheroids
Julian M. Rozenberg, Gleb I. Filkov, Alexander V. Trofimenko, Evgeny A. Karpulevich, Vladimir D. Parshin, Valery V. Royuk, Marina I. Sekacheva and Mikhail O. Durymanov
Front. Oncol., 2021, 11
DOI: 10.3389/fonc.2021.791069

Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids
Devanjali Dutta, L. Francisco Lorenzo-Martín, François Rivest, Nicolas Broguiere, Lucie Tillard, Simone Ragusa, Nathalie Brandenberg, Sylke Höhnel, Damien Saugy, Sylvie Rusakiewicz, Krisztian Homicsko, George Coukos and Matthias P. Lutolf
npj Precis. Onc., 2024, 8
DOI: 10.1038/s41698-024-00661-3

Physiomimetic Models of Adenomyosis
Juan S. Gnecco, Alex T. Brown, Ellen L. Kan, Lauren Baugh, Clara Ives, Megan Loring and Linda G. Griffith
Semin Reprod Med, 2020, 38, 179
DOI: 10.1055/s-0040-1719084

Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or-yam Revach, Seth Anderson, Emily A. Kessler, Clara H. Wolfe, Anne Jenney, Caitlin E. Mills, Emily J. Robitschek, Thomas G. R. Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P. Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M. Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A. Michaud, Rodrigo Saad-Beretta, Kathleen B. Yates, Arvin Iracheta-Vellve, Johan K. E. Spetz, Xingping Qin, Kristopher A. Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y. Su, Angelina M. Cicerchia, Martin Q. Rasmussen, Samuel J. Klempner, Dejan Juric, Sara I. Pai, David M. Miller, Anita Giobbie-Hurder, Jonathan H. Chen, Karin Pelka, Dennie T. Frederick, Susanna Stinson, Elena Ivanova, Amir R. Aref, Cloud P. Paweletz, David A. Barbie, Debattama R. Sen, David E. Fisher, Ryan B. Corcoran, Nir Hacohen, Peter K. Sorger, Keith T. Flaherty, Genevieve M. Boland, Robert T. Manguso and Russell W. Jenkins
Nature, 2023, 615, 158
DOI: 10.1038/s41586-023-05704-6

Inspiring a convergent engineering approach to measure and model the tissue microenvironment
Rishyashring R. Iyer, Catherine C. Applegate, Opeyemi H. Arogundade, Sushant Bangru, Ian C. Berg, Bashar Emon, Marilyn Porras-Gomez, Pei-Hsuan Hsieh, Yoon Jeong, Yongdeok Kim, Hailey J. Knox, Amir Ostadi Moghaddam, Carlos A. Renteria, Craig Richard, Ashlie Santaliz-Casiano, Sourya Sengupta, Jason Wang, Samantha G. Zambuto, Maria A. Zeballos, Marcia Pool, Rohit Bhargava and H. Rex Gaskins
Heliyon, 2024, 10, e32546
DOI: 10.1016/j.heliyon.2024.e32546

Dual‐Sensing Nanoreporter for Dynamic and High‐Throughput Monitoring of Immune Checkpoint Inhibitor Responses in Tumor‐Derived Organoids
Anh Nguyen, Anujan Ramesh, Adam Fish and Ashish A. Kulkarni
Adv Funct Materials, 2024, 34
DOI: 10.1002/adfm.202400393

Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Navin R. Mahadevan, Erik H. Knelson, Jacquelyn O. Wolff, Amir Vajdi, Maria Saigí, Marco Campisi, Deli Hong, Tran C. Thai, Brandon Piel, Saemi Han, Bruce B. Reinhold, Jonathan S. Duke-Cohan, Michael J. Poitras, Luke J. Taus, Patrick H. Lizotte, Andrew Portell, Victor Quadros, Alison D. Santucci, Takahiko Murayama, Israel Cañadas, Shunsuke Kitajima, Aoi Akitsu, Maya Fridrikh, Hideo Watanabe, Brendan Reardon, Prafulla C. Gokhale, Cloud P. Paweletz, Mark M. Awad, Eliezer M. Van Allen, Ana Lako, Xi-Tao Wang, Benjamin Chen, Fangxin Hong, Lynette M. Sholl, Michael Y. Tolstorukov, Kathleen Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott Rodig, Ellis L. Reinherz, Matthew G. Oser and David A. Barbie
Cancer Discovery, 2021, 11, 1952
DOI: 10.1158/2159-8290.CD-20-0913

Microgravity-cultured glioblastoma organoids integrated with microfluidic chip for CAR-γδ T evaluation
Guidong Zhu, Xiaoxue Shi, Ying Jiang, Wen Zhang, Linpei Guo, Guojing Pei, Yingchao Liu, Dongqi Tang, Chengwei Wang and Zhongzheng Sun
Commun Biol, 2025, 8
DOI: 10.1038/s42003-025-09390-0

Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Tengku Ibrahim Maulana, Elena Kromidas, Lars Wallstabe, Madalena Cipriano, Miriam Alb, Cécile Zaupa, Michael Hudecek, Birgit Fogal and Peter Loskill
Advanced Drug Delivery Reviews, 2021, 173, 281
DOI: 10.1016/j.addr.2021.03.015

Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Irina Veith, Martin Nurmik, Arianna Mencattini, Isabelle Damei, Christine Lansche, Solenn Brosseau, Giacomo Gropplero, Stéphanie Corgnac, Joanna Filippi, Nicolas Poté, Edouard Guenzi, Anaïs Chassac, Pierre Mordant, Jimena Tosello, Christine Sedlik, Eliane Piaggio, Nicolas Girard, Jacques Camonis, Hamasseh Shirvani, Fathia Mami-Chouaib, Fatima Mechta-Grigoriou, Stéphanie Descroix, Eugenio Martinelli, Gérard Zalcman and Maria Carla Parrini
Cell Reports Medicine, 2024, 5, 101549
DOI: 10.1016/j.xcrm.2024.101549

A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno-Therapies
Bin Xue, Julia Schüler, Christopher M. Harrod, Kanstantsin Lashuk, Zoji Bomya and Kolin C. Hribar
Cells, 2023, 12, 1145
DOI: 10.3390/cells12081145

High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment
Ilana Berger Fridman, James Kostas, Michal Gregus, Somak Ray, Matthew R. Sullivan, Alexander R. Ivanov, Smadar Cohen and Tania Konry
Acta Biomaterialia, 2021, 132, 473
DOI: 10.1016/j.actbio.2021.06.025

Modelling the tumor immune microenvironment for precision immunotherapy
Nathan J Mackenzie, Clarissa Nicholls, Abby R Templeton, Mahasha PJ Perera, Penny L Jeffery, Kate Zimmermann, Arutha Kulasinghe, Tony J Kenna, Ian Vela, Elizabeth D Williams and Patrick B Thomas
Clin & Trans Imm, 2022, 11
DOI: 10.1002/cti2.1400

Human biomimetic liver microphysiology systems in drug development and precision medicine
Albert Gough, Alejandro Soto-Gutierrez, Lawrence Vernetti, Mo R. Ebrahimkhani, Andrew M. Stern and D. Lansing Taylor
Nat Rev Gastroenterol Hepatol, 2021, 18, 252
DOI: 10.1038/s41575-020-00386-1

Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
Wai Sun Chan, Xuetang Mo, Philip Pun Ching Ip and Ka Yu Tse
Cancer Medicine, 2023, 12, 19714
DOI: 10.1002/cam4.6521

A hitchhiker’s guide to cancer models
Karim I. Budhwani, Zeelu H. Patel, Rachael E. Guenter and Areesha A. Charania
Trends in Biotechnology, 2022, 40, 1361
DOI: 10.1016/j.tibtech.2022.04.003

Advances in human organs-on-chips and applications for drug screening and personalized medicine
Chenyang Zhou, Zhangjie Li, Kangyi Lu, Yijun Liu, Lian Xuan, Hongju Mao and Xiaolin Wang
Fundamental Research, 2025, 5, 1258
DOI: 10.1016/j.fmre.2023.12.019

A 3D Cell Death Assay to Quantitatively Determine Ferroptosis in Spheroids
Robin Demuynck, Iuliia Efimova, Abraham Lin, Heidi Declercq and Dmitri V. Krysko
Cells, 2020, 9, 703
DOI: 10.3390/cells9030703

Application of organoids in precision immunotherapy of lung cancer (Review)
Huichuan Tian, Jiajun Ren, Ruiyu Mou and Yingjie Jia
Oncol Lett, 2023, 26
DOI: 10.3892/ol.2023.14071

Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment
Bassel Alsaed, Linh Lin, Jieun Son, Jiaqi Li, Johannes Smolander, Timothy Lopez, Pinar Ö. Eser, Atsuko Ogino, Chiara Ambrogio, Yoonji Eum, Tran Thai, Haiyun Wang, Eva Sutinen, Hilma Mutanen, Hanna Duàn, Nina Bobik, Kristian Borenius, William W. Feng, Behnam Nabet, Satu Mustjoki, Sanna Laaksonen, Benjamin K. Eschle, Michael J. Poitras, David Barbie, Ilkka Ilonen, Prafulla Gokhale, Pasi A. Jänne and Heidi M. Haikala
Nat Commun, 2025, 16
DOI: 10.1038/s41467-024-55378-5

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
Francisco Hermida-Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi, Zhengtao Chu, Avery Feit, Marco Campisi, Minyue Chen, Agostina Nardone, Cristina Guarducci, Klothilda Lim, Alba Font-Tello, Irene Lee, Juana García-Pedrero, Israel Cañadas, Judith Agudo, Ying Huang, Tal Sella, Qingchun Jin, Nabihah Tayob, Elizabeth A. Mittendorf, Sara M. Tolaney, Xintao Qiu, Henry Long, William F. Symmans, Jia-Ren Lin, Sandro Santagata, Isabelle Bedrosian, Denise A. Yardley, Ingrid A. Mayer, Edward T. Richardson, Giacomo Oliveira, Catherine J. Wu, Eugene F. Schuster, Mitch Dowsett, Alana L. Welm, David Barbie, Otto Metzger and Rinath Jeselsohn
Cancer Research, 2023, 83, 3284
DOI: 10.1158/0008-5472.CAN-23-1711

Toward reproducible tumor organoid culture: focusing on primary liver cancer
Lianming Guo, Chao Li and Weiqiang Gong
Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1290504

Tumor-on-chip modeling of organ-specific cancer and metastasis
Nuala Del Piccolo, Venktesh S. Shirure, Ye Bi, S. Peter Goedegebuure, Sepideh Gholami, Christopher C.W. Hughes, Ryan C. Fields and Steven C. George
Advanced Drug Delivery Reviews, 2021, 175, 113798
DOI: 10.1016/j.addr.2021.05.008

Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer
Mauro Di Pilato, Yun Gao, Yi Sun, Amina Fu, Carina Grass, Thomas Seeholzer, Regina Feederle, Irina Mazo, Samuel W. Kazer, Kevin Litchfield, Ulrich H. von Andrian, Thorsten R. Mempel, Russell W. Jenkins, Daniel Krappmann and Peter Keller
Journal of Immunotherapy and Precision Oncology, 2023, 6, 61
DOI: 10.36401/JIPO-22-18

Liver organoids and their application in liver cancer research
Xinyu Song, Kaifei Hou, Hongyan Zhou, Jingyi Yang, Ting Cao and Jiayu Zhang
Regenerative Therapy, 2024, 25, 128
DOI: 10.1016/j.reth.2023.12.011

PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem?
Shruthi Narayanan, Silve Vicent and Mariano Ponz-Sarvisé
Front. Cell Dev. Biol., 2021, 9
DOI: 10.3389/fcell.2021.787249

The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors
Grissel Trujillo-de Santiago, Brenda Giselle Flores-Garza, Jorge Alfonso Tavares-Negrete, Itzel Montserrat Lara-Mayorga, Ivonne González-Gamboa, Yu Shrike Zhang, Augusto Rojas-Martínez, Rocío Ortiz-López and Mario Moisés Álvarez
Materials, 2019, 12, 2945
DOI: 10.3390/ma12182945

Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform
Yuqing Zhang, Zehua Li, Jessica Ritter, Elliott J. Brea, Navin R. Mahadevan, Deborah A. Dillon, Sung-Rye Park, Eric Minwei Liu, Michael Y. Tolstorukov, William E. McGourty, Patrick Lizotte, Elena V. Ivanova, Caroline Fahey, Koji Haratani, Tran C. Thai, Kara M. Soroko, Sophie Kivlehan, Eric L. Smith, Prafulla C. Gokhale, Cloud P. Paweletz, David A. Barbie and Thanh U. Barbie
Cell Reports Medicine, 2025, 6, 102198
DOI: 10.1016/j.xcrm.2025.102198

Tumor organoids: Opportunities and challenges to guide precision medicine
Vivien Veninga and Emile E. Voest
Cancer Cell, 2021, 39, 1190
DOI: 10.1016/j.ccell.2021.07.020

Cycling molecular assemblies for Golgi imaging and disruption
Weiyi Tan, Qiuxin Zhang, Zhiyu Liu, Kangqiang Qiu, Divyanshu Mahajan, Thomas Gerton, Noah Copperman, Erica C. Dresselhaus, Chaoshuang Xia, Cheng Lin, William Lau, Mikki Lee, Isabela Ashton-Rickardt, Pengyu Hong, Daniela Dinulescu, Jer-Tsong Hsieh, Avital A. Rodal, David M. Loeb, Ronny Drapkin, Jiajie Diao, Lei Lu and Bing Xu
Nat Commun, 2026, 17
DOI: 10.1038/s41467-026-68768-8

Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, Karl-Heinz Krause, Thomas Matthes and Olivier Preynat-Seauve
Cells, 2023, 12, 1001
DOI: 10.3390/cells12071001

Cultivation of Melanoma Cells in vitro on a 3D Scaffold Prepared on the Basis of Gelatin
A. A. Yatsenko, V. A. Kushnarev, E. M. Ustinov, D. V. Leonov, V. M. Kislitskiy, S. S. Tseluyko and A. S. Artemieva
Cell Tiss. Biol., 2020, 14, 474
DOI: 10.1134/S1990519X20060097

Tumor organoids targeted by receptor-engineered immune cells: A promising approach for advancing cancer immunotherapy
Qunfang Zhang, Huazhen Liu, Xiaoli Zhang, Huijuan Wang, Weihui Lu and Zhenhua Dai
International Immunopharmacology, 2025, 165, 115449
DOI: 10.1016/j.intimp.2025.115449

Microporogen‐Structured Collagen Matrices for Embedded Bioprinting of Tumor Models for Immuno‐Oncology
Daniel S. Reynolds, Irene de Lázaro, Manon L. Blache, Yutong Liu, Nicholas C. Jeffreys, Ramsey M. Doolittle, Estée Grandidier, Jason Olszewski, Mason T. Dacus, David J. Mooney and Jennifer A. Lewis
Advanced Materials, 2023, 35
DOI: 10.1002/adma.202210748

Patient-derived melanoma models
Franziska Karras and Manfred Kunz
Pathology - Research and Practice, 2024, 259, 155231
DOI: 10.1016/j.prp.2024.155231

Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future
Victoria Judith Morel, Jochen Rössler and Michele Bernasconi
Medicinal Research Reviews, 2024, 44, 2730
DOI: 10.1002/med.22059

Deciphering Breast Tumor Heterogeneity Through Patient-Derived Organoids and Circulating Tumor Cells
Benedetta Policastro, Nikoline Nissen and Carla L. Alves
JPM, 2025, 15, 271
DOI: 10.3390/jpm15070271

Reconstruction of tumor microenvironment via in vitro three-dimensional models
Zhenzhen Zhou, Jianyu He, Yuan Pang and Wei Sun
Biofabrication, 2023, 15, 032002
DOI: 10.1088/1758-5090/acd1b8

Activation of Tumor-Cell STING Primes NK-Cell Therapy
Erik H. Knelson, Elena V. Ivanova, Mubin Tarannum, Marco Campisi, Patrick H. Lizotte, Matthew A. Booker, Ismail Ozgenc, Moataz Noureddine, Brittany Meisenheimer, Minyue Chen, Brandon Piel, Nathaniel Spicer, Bonje Obua, Cameron M. Messier, Erin Shannon, Navin R. Mahadevan, Tetsuo Tani, Pieter J. Schol, Anna M. Lee-Hassett, Ari Zlota, Ha V. Vo, Minh Ha, Arrien A. Bertram, Saemi Han, Tran C. Thai, Corinne E. Gustafson, Kartika Venugopal, Timothy J. Haggerty, Thomas P. Albertson, Antja-Voy Hartley, Pinar O. Eser, Ze-Hua Li, Israel Cañadas, Marina Vivero, Assunta De Rienzo, William G. Richards, Adnan O. Abu-Yousif, Vicky A. Appleman, Richard C. Gregory, Alexander Parent, Neil Lineberry, Eric L. Smith, Pasi A. Jänne, Juan J. Miret, Michael Y. Tolstorukov, Rizwan Romee, Cloud P. Paweletz, Raphael Bueno and David A. Barbie
Cancer Immunology Research, 2022, 10, 947
DOI: 10.1158/2326-6066.CIR-22-0017

3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models
Maria V. Monteiro, Yu Shrike Zhang, Vítor M. Gaspar and João F. Mano
Trends in Biotechnology, 2022, 40, 432
DOI: 10.1016/j.tibtech.2021.08.007

Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy
Myagmartsend Enkhbat, Yung‐Chiang Liu, Jua Kim, Yanshan Xu, Zongyi Yin, Tzu‐Ming Liu, Chu‐Xia Deng, Chang Zou, Xi Xie, Xiaowu Li and Peng‐Yuan Wang
Advanced Therapeutics, 2021, 4
DOI: 10.1002/adtp.202100017

Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
Kaiwen Chen, Yanran Li, Bingran Wang, Xuehan Yan, Yiying Tao, Weizhou Song, Zhifeng Xi, Kang He and Qiang Xia
Front. Immunol., 2023, 14
DOI: 10.3389/fimmu.2023.1101324

Protocol for the preparation and analysis of patient-derived organotypic tumor spheroids
Claire A. Palin, Russell W. Jenkins and Or-Yam Revach
STAR Protocols, 2026, 7, 104286
DOI: 10.1016/j.xpro.2025.104286

Effects of Wound Fluid on Breast Cancer-derived Spheroids in a 3D Culture System: A Case Series Study
Ali Hojat, Shabnam Jeibouei, Amir Reza Aref, Alireza Kalbasi, Maryam Moghaddam, Farzaneh Mohammadi, Seyed Mohammadreza Javadi, Mohammad Ajoudanian, Kazem Sharifi, Hakimeh Zali and Mohammad Esmaeil Akbari
Iran J Pharm Res, 2021, 21
DOI: 10.5812/ijpr.123828

3D cancer models: One step closer to in vitro human studies
Nicoletta Manduca, Ester Maccafeo, Ruggero De Maria, Antonella Sistigu and Martina Musella
Front. Immunol., 2023, 14
DOI: 10.3389/fimmu.2023.1175503

Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells
Peng Li, Minli Huang, Yifan Ma, Yongbin Zhang and Changhong Shi
Cancer Cell Int, 2024, 24
DOI: 10.1186/s12935-024-03628-3

Patient-derived tumor organoids for cancer immunotherapy: culture techniques and clinical application
Ningning Yao, Na Jing, Jianzhong Lin, Wenxia Niu, Wenxing Yan, Hongqin Yuan, Zeyi Xiong, Qing Hou, Xiaxi Qiao, Quanming Liu, Jianzhong Cao and Ning Li
Invest New Drugs, 2025, 43, 394
DOI: 10.1007/s10637-025-01523-w

Microdissection tools to generate organoids for modeling the tumor immune microenvironment
Seth C. Cordts, Kanako Yuki, Maria F. Henao Echeverri, Balasubramanian Narasimhan, Calvin J. Kuo and Sindy K. Y. Tang
Microsyst Nanoeng, 2024, 10
DOI: 10.1038/s41378-024-00756-8

Organoid Models for Precision Cancer Immunotherapy
Cai-Ping Sun, Huan-Rong Lan, Xing-Liang Fang, Xiao-Yun Yang and Ke-Tao Jin
Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.770465

Recent advances in microfluidic-based cancer immunotherapy-on-a-chip strategies
Thi Kim Ngan Ngo, Cheng-Hsiang Kuo and Ting-Yuan Tu
Biomicrofluidics, 2023, 17
DOI: 10.1063/5.0108792

Tumor-Derived cGAMP Regulates Activation of the Vasculature
Marco Campisi, Shriram K. Sundararaman, Sarah E. Shelton, Erik H. Knelson, Navin R. Mahadevan, Ryohei Yoshida, Tetsuo Tani, Elena Ivanova, Israel Cañadas, Tatsuya Osaki, Sharon Wei Ling Lee, Tran Thai, Saemi Han, Brandon P. Piel, Sean Gilhooley, Cloud P. Paweletz, Valeria Chiono, Roger D. Kamm, Shunsuke Kitajima and David A. Barbie
Front. Immunol., 2020, 11
DOI: 10.3389/fimmu.2020.02090

Recapitulating the Cancer‐Immunity Cycle on a Chip
Yujin Lee, Jaehong Min, Solbin Kim, Wooju Park, Jihoon Ko and Noo Li Jeon
Adv Healthcare Materials, 2025, 14
DOI: 10.1002/adhm.202401927

Organoid models of the tumor microenvironment and their applications
Tao Xia, Wen‐Lin Du, Xiao‐Yi Chen and You‐Ni Zhang
J Cellular Molecular Medi, 2021, 25, 5829
DOI: 10.1111/jcmm.16578

Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization
Yuting Li, Honghong Fan, Junli Ding, Junying Xu, Chaoying Liu and Huiyu Wang
Front. Genet., 2022, 13
DOI: 10.3389/fgene.2022.969723

Low-cost robotic manipulation of live microtissues for cancer drug testing
Ivan Stepanov, Noah R. Gottshall, Alireza Ahmadianyazdi, Daksh Sinha, Ethan J. Lockhart, Tran N. H. Nguyen, Sarmad Hassan, Lisa F. Horowitz, Raymond S. Yeung, Taranjit S. Gujral and Albert Folch
Sci. Adv., 2025, 11
DOI: 10.1126/sciadv.ads1631

Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies
Marco Campisi, Sarah E. Shelton, Minyue Chen, Roger D. Kamm, David A. Barbie and Erik H. Knelson
Cancers, 2022, 14, 3561
DOI: 10.3390/cancers14153561

Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture models
Jeremy A. Lombardo, Marzieh Aliaghaei, Quy H. Nguyen, Kai Kessenbrock and Jered B. Haun
Nat Commun, 2021, 12
DOI: 10.1038/s41467-021-23238-1

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy
Albert Manzano-Muñoz, José Yeste, María A. Ortega, Fernando Martín, Anna López, Jordi Rosell, Sandra Castro, César Serrano, Josep Samitier, Javier Ramón-Azcón and Joan Montero
npj Precis. Onc., 2022, 6
DOI: 10.1038/s41698-022-00333-0

Cells in the 3D biomatrix on-chip: better mimicking the real micro-physiological system
Michele D’Orazio, Joanna Filippi, Gianni Antonelli, Giorgia Curci, Paola Casti, Arianna Mencattini, Gianluca Cidonio and Eugenio Martinelli
Next Materials, 2024, 5, 100229
DOI: 10.1016/j.nxmate.2024.100229

Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma
Tamás Sükei, Elena Palma and Luca Urbani
Cancers, 2021, 13, 5586
DOI: 10.3390/cancers13215586

Applications of Organoids in Advancing Drug Discovery and Development
Indiwari Gopallawa, Charu Gupta, Rayan Jawa, Arya Cyril, Vibha Jawa, Narendra Chirmule and Vikramsingh Gujar
Journal of Pharmaceutical Sciences, 2024, 113, 2659
DOI: 10.1016/j.xphs.2024.06.016

Reconfigurable Microphysiological Systems for Modeling Innervation and Multitissue Interactions
Jonathan R. Soucy, Adam J. Bindas, Ryan Brady, Tess Torregrosa, Cailey M. Denoncourt, Sanjin Hosic, Guohao Dai, Abigail N. Koppes and Ryan A. Koppes
Adv. Biosys., 2020, 4
DOI: 10.1002/adbi.202000133

Engineering immune-competent niches: strategies, applications, and translational hurdles in ovarian cancer organoid models
Yuying Chen, Na Xu, Mingxin Dong, Wensen Liu, Ziwei Liu, Guangchao Sun and Yan Jia
Front. Immunol., 2026, 17
DOI: 10.3389/fimmu.2026.1773734

Tümör-Bağışıklık Hücre Etkileşimlerini Araştırmak İçin Biyomühendisliksel Yöntemler
Tuğba Topal and Zehra Ece Uzun
Gazi Üniversitesi Fen Fakültesi Dergisi, 2025, 6, 343
DOI: 10.63716/guffd.1768168

The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
Eleonore Fröhlich
IJMS, 2023, 24, 7116
DOI: 10.3390/ijms24087116

Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
Satyaki Sengupta, Sanjukta Das, Angela C. Crespo, Annelisa M. Cornel, Anand G. Patel, Navin R. Mahadevan, Marco Campisi, Alaa K. Ali, Bandana Sharma, Jared H. Rowe, Hao Huang, David N. Debruyne, Esther D. Cerda, Malgorzata Krajewska, Ruben Dries, Minyue Chen, Shupei Zhang, Luigi Soriano, Malkiel A. Cohen, Rogier Versteeg, Rudolf Jaenisch, Stefani Spranger, Rizwan Romee, Brian C. Miller, David A. Barbie, Stefan Nierkens, Michael A. Dyer, Judy Lieberman and Rani E. George
Nat Cancer, 2022, 3, 1228
DOI: 10.1038/s43018-022-00427-5

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment
Jie Zhang, Hamed Tavakoli, Lei Ma, Xiaochun Li, Lichun Han and XiuJun Li
Advanced Drug Delivery Reviews, 2022, 187, 114365
DOI: 10.1016/j.addr.2022.114365

Modelling the colorectal cancer immune microenvironment using air–liquid interface organoids for personalised therapeutic evaluation
Rebeca Abad Moret, Esteban Díaz, Laura Córdoba, Sylwia Bilas, Teresa Gómez-Elvira, Natalia González Alcolea, Beatriz Díaz San Andrés, Francisco J Cueto, Eduardo López-Collazo and Ramón Cantero Cid
Cirugía Española (English Edition), 2026, 800285
DOI: 10.1016/j.cireng.2026.800285

Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
Jialong Zhu, Linlin Ji, Yitian Chen, Huiyu Li, Mengxi Huang, Zhe Dai, Jing Wang, Dan Xiang, Gongbo Fu, Zengjie Lei and Xiaoyuan Chu
Cell Death Discov., 2023, 9
DOI: 10.1038/s41420-023-01354-9

Oncoimmunology Meets Organs-on-Chip
Fabrizio Mattei, Sara Andreone, Arianna Mencattini, Adele De Ninno, Luca Businaro, Eugenio Martinelli and Giovanna Schiavoni
Front. Mol. Biosci., 2021, 8
DOI: 10.3389/fmolb.2021.627454

Irreversible electroporation for post-operative margin therapy to prevent cancer recurrence based on triboelectric nanogenerator driven balloon catheter
Mohammad Ali Khayamian, Hamed Abadijoo, Shahriar Shalileh, Mohammadreza Ghaderinia, Hossein Simaee, Fereshteh Abbasvandi, Mohammad Reza Esmailinejad, Hassan Sanati, Hadi Ghafari, Mohammad Salemizadeh Parizi, Shohreh Vanaei, Navid Akbari, Arash Karimi, Seyed Mojtaba Yazdanparast, Farshid Rostami Pouria, Bahman Ghabraie, Mahsa Faramarzpour, Reyhaneh Shakibi, Ebrahim Kousha, Ashkan Zandi, Parisa Hoseinpour, Alireza Vajhi, Ramin Sarrami-Forooshani and Mohammad Abdolahad
Nano Energy, 2023, 112, 108510
DOI: 10.1016/j.nanoen.2023.108510

Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
Li-Feng Hu, Xue Yang, Huan-Rong Lan, Xing-Liang Fang, Xiao-Yi Chen and Ke-Tao Jin
Experimental Cell Research, 2021, 408, 112858
DOI: 10.1016/j.yexcr.2021.112858

Applications of Omics Technologies for Three-Dimensional In Vitro Disease Models
Vera M. Pieters, Ileana L. Co, Nila C. Wu and Alison P. McGuigan
Tissue Engineering Part C: Methods, 2021, 27, 183
DOI: 10.1089/ten.tec.2020.0300

Organ-on-Chip platforms to study tumor evolution and chemosensitivity
Venzil Lavie Dsouza, Raviprasad Kuthethur, Shama Prasada Kabekkodu and Sanjiban Chakrabarty
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022, 1877, 188717
DOI: 10.1016/j.bbcan.2022.188717

Toward improved in vitro models of human cancer
Jose M. Ayuso, Keon-Young Park, María Virumbrales-Muñoz and David J. Beebe
APL Bioengineering, 2021, 5
DOI: 10.1063/5.0026857

Application and research progress of in vitro liver cancer cell culture models
Jia-Li Xing, Yu-Xin Wang and Shun-Da Du
WCJD, 2021, 29, 563
DOI: 10.11569/wcjd.v29.i11.563

Recent Trends and Opportunities for the Targeted Immuno-Nanomaterials for Cancer Theranostics Applications
Clyde John, Kaahini Jain, Hema Brindha Masanam, Ashwin Kumar Narasimhan and Arutselvan Natarajan
Micromachines, 2022, 13, 2217
DOI: 10.3390/mi13122217

Microphysiological Systems as Enabling Tools for Modeling Complexity in the Tumor Microenvironment and Accelerating Cancer Drug Development
Hong Nam Kim, Nicole L. Habbit, Chia‐Yi Su, Nakwon Choi, Eun Hyun Ahn, Elizabeth A. Lipke and Deok‐Ho Kim
Adv Funct Materials, 2019, 29
DOI: 10.1002/adfm.201807553

Reproducible extracellular matrices for tumor organoid culture: challenges and opportunities
Kan Li, Yibo He, Xue Jin, Ketao Jin and Jun Qian
J Transl Med, 2025, 23
DOI: 10.1186/s12967-025-06349-x

Ex Vivo Intestinal Organoid Models: Current State-of-the-Art and Challenges in Disease Modelling and Therapeutic Testing for Colorectal Cancer
Sarron Randall-Demllo, Ghanyah Al-Qadami, Anita E. Raposo, Chenkai Ma, Ilka K. Priebe, Maryam Hor, Rajvinder Singh and Kim Y. C. Fung
Cancers, 2024, 16, 3664
DOI: 10.3390/cancers16213664

3D Tumor Models and Their Use for the Testing of Immunotherapies
Nicolas Boucherit, Laurent Gorvel and Daniel Olive
Front. Immunol., 2020, 11
DOI: 10.3389/fimmu.2020.603640

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
Zilong Zhou, Lele Cong and Xianling Cong
Front. Oncol., 2021, 11
DOI: 10.3389/fonc.2021.762184

Overcoming Resistance Mechanisms to Melanoma Immunotherapy
David X. Zheng, David J. Bozym, Giuseppe Tarantino, Ryan J. Sullivan, David Liu and Russell W. Jenkins
Am J Clin Dermatol, 2025, 26, 77
DOI: 10.1007/s40257-024-00907-7

Immune organoids: from tumor modeling to precision oncology
Vinh Dao, Kanako Yuki, Yuan-Hung Lo, Michitaka Nakano and Calvin J. Kuo
Trends in Cancer, 2022, 8, 870
DOI: 10.1016/j.trecan.2022.06.001

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies
Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci, Patrick C. Gedeon, Kendall J. Condon, Suhasini Joshi, Shana Posy, Patrick Carlson, Alison Maier, Jiao Shen, Rakeeb Kureshi, Yuka Amako, Tai Wang, Ryan L. Powles, Yanyun Li, Tho Lai, Igor Katsyv, Hongchen Qiu, Huilin Qi, Jessica Wong, Dandan Zhao, Dana Banas, Joelle Onorato, Gregory Locke, Xueer Chen, Wen-Chi Chou, Erica Cook, Abigail E. Witt, Christopher M. Barbieri, Hong Zhang, Jonathan B. Olsen, Alba Font Tello, Eugene Drokhlyansky, Denise C. Grünenfelder, Louis Chupak, Tyler A. Longmire, Jon C. Jones, Travis J. Hollmann, David G. Kugler, John N. Feder, Raphael Bueno, John Wain, Pallavur Sivakumar, Yu Liu, Stephanie K. Dougan, Cloud P. Paweletz, David A. Barbie and Emma Lees
Cancer Immunology Research, 2025, 13, 1342
DOI: 10.1158/2326-6066.CIR-25-0156

In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment
Dmitri V. Krysko, Robin Demuynck, Iuliia Efimova, Faye Naessens, Olga Krysko and Elena Catanzaro
Cells, 2022, 11, 3705
DOI: 10.3390/cells11223705

Spatiotemporal dissection of tumor microenvironment via in situ sensing and monitoring in tumor-on-a-chip
Lang Zhou, Lunan Liu, Muammar Ali Chang, Chao Ma, Weiqiang Chen and Pengyu Chen
Biosensors and Bioelectronics, 2023, 225, 115064
DOI: 10.1016/j.bios.2023.115064

Bioengineered tumor organoids
Anthony Dominijanni, Andrea Mazzocchi, Ethan Shelkey, Steven Forsythe, Mahesh Devarsetty and Shay Soker
Current Opinion in Biomedical Engineering, 2020, 13, 168
DOI: 10.1016/j.cobme.2020.03.005

Colorectal Air–Liquid Interface Organoids Preserve Tumour-Immune Architecture and Reveal Local Treg Expansion After PD-1 Blockade
Laura Córdoba, Francisco J. Cueto, Ramón Cantero-Cid, Rebeca Abad-Moret, Esteban Díaz, Jaime Álvarez-Benayas, Jesús Fernández-Felipe, Jesús Jiménez-Rodríguez, Daniel Arvelo-Rosario, Pablo Mata-Martínez, Marina Arranz-Álvarez, Yaiza Pedroche-Just, Sandra Nieto-Torrero, Jaime Valentín-Quiroga, Verónica Terrón-Arcos, Jaime Fernández-Pascual, Paloma Gómez-Campelo, Nieves Cubo-Mateo, Olivia Fernández-Medina, Laura Hurtado-Navarro, Gonzalo Sáenz de Santa María, Julia del Prado-Montero, Agustín L. Santos, Roberto Lozano-Rodríguez, Carlos del Fresno and Eduardo López-Collazo
Cancers, 2025, 18, 132
DOI: 10.3390/cancers18010132

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang and Calvin J. Kuo
Nat Rev Cancer, 2024, 24, 523
DOI: 10.1038/s41568-024-00706-6

Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, Chiara Damiani, Valentina Pasquale, Elena Sacco, Marco Vanoni and Mara Gilardi
Front. Oncol., 2023, 13
DOI: 10.3389/fonc.2023.1164535

Intestinal organ chips for disease modelling and personalized medicine
Alican Özkan, Nina Teresa LoGrande, Jessica F. Feitor, Girija Goyal and Donald E. Ingber
Nat Rev Gastroenterol Hepatol, 2024, 21, 751
DOI: 10.1038/s41575-024-00968-3

All‐in‐one microfluidic design to integrate vascularized tumor spheroid into high‐throughput platform
Youngtaek Kim, Jihoon Ko, Nari Shin, Seonghyuk Park, Seung‐Ryeol Lee, Suryong Kim, Jiyoung Song, Seokjun Lee, Kyung‐Sun Kang, Jeeyun Lee and Noo Li Jeon
Biotech & Bioengineering, 2022, 119, 3678
DOI: 10.1002/bit.28221

Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer
Yulia I. Nussbaum, Yariswamy Manjunath, Kanve N. Suvilesh, Wesley C. Warren, Chi-Ren Shyu, Jussuf T. Kaifi, Matthew A. Ciorba and Jonathan B. Mitchem
IJMS, 2021, 22, 4802
DOI: 10.3390/ijms22094802

High-throughput spheroid-based assay for functional breast cancer precision medicine facilitated by deep learning
Ben Haspels, Maarten W. Paul, Jayant Jagessar Tewari, Mieke Bavelaar, Zofia M. Komar, Jos Jonkers, Roland Kanaar, Dik C. van Gent and Maayke M. P. Kuijten
Commun Med, 2026, 6
DOI: 10.1038/s43856-025-01359-8

Advances in Modeling the Immune Microenvironment of Colorectal Cancer
Paul Sukwoo Yoon, Nuala Del Piccolo, Venktesh S. Shirure, Yushuan Peng, Amanda Kirane, Robert J. Canter, Ryan C. Fields, Steven C. George and Sepideh Gholami
Front. Immunol., 2021, 11
DOI: 10.3389/fimmu.2020.614300

Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer
Chang Liu, Kaiyi Li, Xizhao Sui, Tian Zhao, Ting Zhang, Zhongyao Chen, Hainan Wu, Chao Li, Hao Li, Fan Yang, Zhidong Liu, You‐Yong Lu, Jun Wang, Xiaofang Chen and Peng Liu
Advanced Science, 2024, 11
DOI: 10.1002/advs.202400185

Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Santa Bērziņa, Alexandra Harrison, Valérie Taly and Wenjin Xiao
Cancers, 2021, 13, 4192
DOI: 10.3390/cancers13164192

Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, Murali Munisamy, Anvita Gupta Malhotra, Jitendra Singh, Ashok Kumar, Vivek M. Rangnekar, Neha Arya and Mahadev Rao
Mol Cancer, 2024, 23
DOI: 10.1186/s12943-023-01916-6

Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment
Daniel T. Doty, Julia Schueler, Vienna L. Mott, Cassie M. Bryan, Nathan F. Moore, John C. Ho and Jeffrey T. Borenstein
IJMS, 2020, 21, 6478
DOI: 10.3390/ijms21186478

Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling
Morgan Craig, Adrianne L. Jenner, Bumseok Namgung, Luke P. Lee and Aaron Goldman
Chem. Rev., 2021, 121, 3352
DOI: 10.1021/acs.chemrev.0c00356

Cancer‐on‐Chip and Integrative Tumor Microenvironment Sensor Technologies for Progressing Precision Radiotherapy
Shuvashis Dey, Masaki Kinoshita, Simon Puttick, Stephen Rose, Matt Trau, Matthew J. Roberts and Kevin M. Koo
Advanced Sensor Research, 2024, 3
DOI: 10.1002/adsr.202300193

Bioengineered tissue models for the development of dynamic immuno-associated tumor models and high-throughput immunotherapy cytotoxicity assays
Amir Seyfoori, Mahdieh Shokrollahi Barough, Meitham Amereh, Bardia Khun Jush, Julian J. Lum and Mohsen Akbari
Drug Discovery Today, 2021, 26, 455
DOI: 10.1016/j.drudis.2020.11.028

The future of microfluidics in immune checkpoint blockade
Jonathan Briones, Wilfred Espulgar, Shohei Koyama, Hyota Takamatsu, Eiichi Tamiya and Masato Saito
Cancer Gene Ther, 2021, 28, 895
DOI: 10.1038/s41417-020-00248-7

Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
Ergang Wang, Kun Xiang, Yun Zhang and Xiao-Fan Wang
Journal of the National Cancer Center, 2022, 2, 263
DOI: 10.1016/j.jncc.2022.10.001

Recent advances of integrated microfluidic suspension cell culture system
Yi Jing Kerk, Aysha Jameel, Xin‐Hui Xing and Chong Zhang
Engineering Biology, 2021, 5, 81
DOI: 10.1049/enb2.12015

Organ-on-a-Chip Applications in Microfluidic Platforms
Ling An, Yi Liu and Yaling Liu
Micromachines, 2025, 16, 201
DOI: 10.3390/mi16020201

Construction and immunotherapy application of lung cancer organoids
Wen Li, Yanlei Ge, Zhi Zhang, Junqing Gan, Weinan Yao, Ye Jin, Yanna Bi and Guogui Sun
Intl Journal of Cancer, 2026, 158, 2795
DOI: 10.1002/ijc.70347

TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi, Ze-Hua Li, Koji Haratani, Caroline G. Fahey, Keiichi Ota, Navin R. Mahadevan, Yingxiao Shi, Shin Saito, Kei Mizuno, Tran C. Thai, Nobunari Sasaki, Mizuki Homme, Choudhury Fabliha B. Yusuf, Adam Kashishian, Jipsa Panchal, Min Wang, Benjamin J. Wolf, Thanh U. Barbie, Cloud P. Paweletz, Prafulla C. Gokhale, David Liu, Ravindra Uppaluri, Shunsuke Kitajima, Jennifer Cain and David A. Barbie
Cancer Discovery, 2024, 14, 752
DOI: 10.1158/2159-8290.CD-23-0700

Advanced technological tools to study multidrug resistance in cancer
Luca Andrei, Sandor Kasas, Ignacio Ochoa Garrido, Tijana Stanković, Mónica Suárez Korsnes, Radka Vaclavikova, Yehuda G. Assaraf and Milica Pešić
Drug Resistance Updates, 2020, 48, 100658
DOI: 10.1016/j.drup.2019.100658

3D models in the new era of immune oncology: focus on T cells, CAF and ECM
Francesca Di Modugno, Cristina Colosi, Paola Trono, Giuseppe Antonacci, Giancarlo Ruocco and Paola Nisticò
J Exp Clin Cancer Res, 2019, 38
DOI: 10.1186/s13046-019-1086-2

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
Fokhrul Hossain, Samarpan Majumder, Justin David and Lucio Miele
Cancers, 2021, 13, 3739
DOI: 10.3390/cancers13153739

A Patient‐Derived Organoid Biobank of Adamantinomatous Craniopharyngioma as a Platform for Drug Discovery
Huarong Zhang, Chaohu Wang, Jun Fan, Zexin Chen, Haoying Yu, Yawen Bai, Tingcheng Zhang, Qianchao Zhu, Yiwen Feng, Peirong Niu, Jiaqian Chen, Liping Yang, Xueying Li, Lei Yu, Songtao Qi and Yi Liu
Advanced Science, 2026, 13
DOI: 10.1002/advs.202503924

Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
Yufei Wang, Alicia Buck, Brandon Piel, Luann Zerefa, Nithyassree Murugan, Christian D. Coherd, Andras G. Miklosi, Haraman Johal, Ricardo Nunes Bastos, Kun Huang, Miriam Ficial, Yasmin Nabil Laimon, Sabina Signoretti, Zhou Zhong, Song-My Hoang, Gabriella M. Kastrunes, Marion Grimaud, Atef Fayed, Hsien-Chi Yuan, Quang-De Nguyen, Tran Thai, Elena V. Ivanova, Cloud P. Paweletz, Ming-Ru Wu, Toni K. Choueiri, Jon O. Wee, Gordon J. Freeman, David A. Barbie and Wayne A. Marasco
Mol Cancer, 2024, 23
DOI: 10.1186/s12943-024-01952-w

Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research
Miao Zhu, Tiantian Li, Sen Han, Dongyi Zhao, Xueqing Chen, Vera Wong, Haibo Wang and Yanqing Liu
European J of Haematology, 2025, 115, 322
DOI: 10.1111/ejh.14448

Immune-reactive tumor organoids system to determine the effects of microbial metabolites on cancer immunity and immunotherapies
Azza M. El-Derby, Cecilia R. Schaaf, Ethan Shelkey, Katherine L. Cook, Konstantinos I. Votanopoulos and Shay Soker
Front. Microbiomes, 2024, 3
DOI: 10.3389/frmbi.2024.1411322

Mesenchymal stem cells induce PD‐L1 expression through the secretion of CCL5 in breast cancer cells
Hamidreza Aboulkheyr Es, Bahareh Bigdeli, Sareh Zhand, Amir R. Aref, Jean P. Thiery and Majid E. Warkiani
Journal Cellular Physiology, 2021, 236, 3918
DOI: 10.1002/jcp.30135

Developing and validating model systems for immuno-oncology
Claire E. McCarthy, Nastaran Zahir, Mariam Eljanne, Elad Sharon, Emile E. Voest and Karolina Palucka
Cancer Cell, 2021, 39, 1018
DOI: 10.1016/j.ccell.2021.05.017

Design patterns of tumor-on-chips utilizing fluidic devices and their latest trends
Nobuhito Mori and Yasuyuki S. Kida
DDS, 2024, 39, 184
DOI: 10.2745/dds.39.184

Modeling intratumor heterogeneity in breast cancer
Elizabeth McDonough, Margarida Barroso, Fiona Ginty and David T Corr
Biofabrication, 2025, 17, 012009
DOI: 10.1088/1758-5090/ad9b50

Establishment of patient‐derived organotypic tumor spheroid models for tumor microenvironment modeling
Hye Kyung Hong, Nak Hyeon Yun, Ye‐Lin Jeong, Jeehun Park, Junsang Doh, Woo Yong Lee and Yong Beom Cho
Cancer Medicine, 2021, 10, 5589
DOI: 10.1002/cam4.4114

Evaluation of Multispecific Drugs Based on Patient‐Derived Immunocompetent Tumor Organoids
Zihan Zhao, Xiangyu Wu, Tianyang Zhang, Meng Zhou, Siyang Liu, Rong Yang and Jie P. Li
ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202400731

Three-dimensional cell models for studying tumor–immune interactions and testing immunotherapeutic drugs
Svetlana Yu. Filippova, Sophia V. Timofeeva, Irina V. Mezhevova, Elena V. Shalashnaya, Lyudmila Ya. Rozenko, Aleksandr V. Shaposhnikov and Inna A. Novikova
Russian Journal of Oncology, 2023, 28, 65
DOI: 10.17816/onco516562

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors
Richard Riedel, Jana Fassunke, Hannah L. Tumbrink, Andreas H. Scheel, Carina Heydt, Lena Hieggelke, Matthias Scheffler, Alena Heimsoeth, Lucia Nogova, Sebastian Michels, Jan-Phillip Weber, Rieke N. Fischer, Anna Eisert, Theresa Westphal, Diana Schaufler, Janna Siemanowski, Michaela A. Ihle, Svenja Wagener-Ryczek, Roberta Castiglione, Roberto Pappesch, Jan Rehker, Jessica Jürgens, Erich Stoelben, Anne Bunck, Carsten Kobe, Sabine Merkelbach-Bruse, Martin L. Sos, Reinhard Büttner and Jürgen Wolf
European Journal of Cancer, 2023, 179, 124
DOI: 10.1016/j.ejca.2022.11.010

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg and Ronit Satchi‐Fainaro
Adv Healthcare Materials, 2026, 15
DOI: 10.1002/adhm.202503198

Patient-Specific Tumor Microenvironment Models
Jung Woo Lee, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim and Se Young Choi
Korean J Urol Oncol, 2021, 19, 197
DOI: 10.22465/kjuo.2021.19.4.197

Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure
Sarah Minkler, Fabrice Lucien, Michael J. Kimber, Dipak K. Sahoo, Agnes Bourgois-Mochel, Margaret Musser, Chad Johannes, Igor Frank, John Cheville, Karin Allenspach and Jonathan P. Mochel
Cancers, 2021, 13, 422
DOI: 10.3390/cancers13030422

Semiconducting polymer dots for multifunctional integrated nanomedicine carriers
Ze Zhang, Chenhao Yu, Yuyang Wu, Zhe Wang, Haotian Xu, Yining Yan, Zhixin Zhan and Shengyan Yin
Materials Today Bio, 2024, 26, 101028
DOI: 10.1016/j.mtbio.2024.101028

Advancing cancer research through organoid technology
Guolong Zeng, Yifan Yu, Meiting Wang, Jiaxing Liu, Guangpeng He, Sixuan Yu, Huining Yan, Liang Yang, Hangyu Li and Xueqiang Peng
J Transl Med, 2024, 22
DOI: 10.1186/s12967-024-05824-1

Oxygen-Rich Graphene/ZnO2-Ag nanoframeworks with pH-Switchable Catalase/Peroxidase activity as O2 Nanobubble-Self generator for bacterial inactivation
Marziyeh Jannesari, Omid Akhavan, Hamid R. Madaah Hosseini and Bita Bakhshi
Journal of Colloid and Interface Science, 2023, 637, 237
DOI: 10.1016/j.jcis.2023.01.079

Triggering triboelectric nanogenerator antibacterial Activities: Effect of charge polarity and host material correlation
Marziyeh Jannesari, Faezeh Ejehi, Niall J. English, Raheleh Mohammadpour, Omid Akhavan and Soroush Shams
Chemical Engineering Journal, 2024, 486, 150036
DOI: 10.1016/j.cej.2024.150036

Imaging‐Based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids
Seong‐Eun Kim, Suji Yun, Junsang Doh and Hong Nam Kim
Adv Healthcare Materials, 2024, 13
DOI: 10.1002/adhm.202400475

Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
Marco Campisi, Tatsuya Osaki, Ian Dryg, Carla Stornante, Jacqueline Wolff, Jason Weirather, Nicholas Weaver, Mubin Tarannum, Ian Gillanders, Alan Bers, Eden Bobilev, Maia S. Lineberry, Pieter Schol, Minyue Chen, Keiichi Ota, Sung R. Park, Caroline G. Fahey, Tran C. Thai, Yixiang Li, Zhaorong Li, Ze-Hua Li, Sarah Shelton, Satomi Hirose, Clare Padrick, Elena Ivanova, Minh Ha, Shaobo Yang, Harrison Olszewski, Sophie Kivlehan, Patrick Lizotte, Kelsey Hagen, Iliana Gjeci, William Haller, Lauren M. Zasadil, Talal El Zarif, Jacob E. Berchuck, Erik H. Knelson, Elliott J. Brea, Igor Odintsov, Tianju Liu, Valeria Chiono, Bishma Tuladhar, Kenneth Ngo, Emily Rosentrater, Jeffrey Raizer, Neil Lineberry, Mriganka Sur, Kathleen Pfaff, Matthew Freedman, F. Stephen Hodi, Michael Y. Tolstorukov, Matthew G. Oser, Michal Sheffer, Constantine S. Mitsiades, Michael J. Barnes, Vicky A. Appleman, Prafulla C. Gokhale, Roger D. Kamm, Cloud P. Paweletz, Rizwan Romee, Scott Rodig, David A. Barbie and Navin R. Mahadevan
Cancer Cell, 2026
DOI: 10.1016/j.ccell.2026.02.008

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
Cristina Mastini, Marco Campisi, Enrico Patrucco, Giulia Mura, Antonio Ferreira, Carlotta Costa, Chiara Ambrogio, Giulia Germena, Cinzia Martinengo, Silvia Peola, Ines Mota, Elena Vissio, Luca Molinaro, Maddalena Arigoni, Martina Olivero, Raffaele Calogero, Nina Prokoph, Fabrizio Tabbò, Brent Shoji, Laurence Brugieres, Birgit Geoerger, Suzanne D. Turner, Carlos Cuesta-Mateos, Deborah D’Aliberti, Luca Mologni, Rocco Piazza, Carlo Gambacorti-Passerini, Giorgio G. Inghirami, Valeria Chiono, Roger D. Kamm, Emilio Hirsch, Raphael Koch, David M. Weinstock, Jon C. Aster, Claudia Voena and Roberto Chiarle
Sci. Transl. Med., 2023, 15
DOI: 10.1126/scitranslmed.abo3826